Gamze Gül Güleç

Dr. Gamze Gül Güleç

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Journal of Chiropractic Medicine
Verified
Journal Article
Closed access
GGGamze Gül Güleç
Gamze Gül Güleç
KOKübra Neslihan Kurt Oktay
Kübra Neslihan Kurt Oktay
İAİlknur Aktaş
İlknur Aktaş
BYBarış Yılmaz
Barış Yılmaz
The aim of this article is to present examples of patients in whom piriformis muscle (PM) and sciatic nerve (SN) variations were detected by a diagnostic ultrasound (US)–guided examination and were successfully diagnosed and treated for piriformis syndrome (PS) by US-guided injections. This series includes 4 cases. In case 1, a 30-year-old woman with a 7 numeric rating scale (NRS) score for pain (on a 0-10 scale) was evaluated for complaints of left gluteal pain radiating to the thigh for 5 years and right gluteal pain for 2 years. Case 2 involves a 32-year-old man with a 7 NRS score presenting with left gluteal pain radiating to his leg for 1 year. The third case presents a 37-year-old man who had pain (6 NRS score), numbness, and discomfort radiating from the right hip to the leg that lasted for 7 years. Finally, in case 4, a 23-year-old male patient was examined with deep gluteal paresthesia and discomfort on the left side for 1 year. Diagnostic US evaluation of the gluteal region for each patient revealed anatomical variations of the SN. In 3 of the cases, corresponding contralateral US images demonstrated similar anatomic variations. Diagnosis of PS in each patient was made by US-guided injection. After the injection of 4 cm3 of lidocaine 2% into the PM, the patients’ complaints resolved almost fully. The anatomical variations of the SN and PM might be a facilitating factor for myofascial pain syndrome in PS. These cases demonstrate that SN variations could be visualized with the help of diagnostic US.

25 March 2023 in Cureus
Verified
Journal Article
Open access
PDF file
GGGamze Gül Güleç
Gamze Gül Güleç
İAİlknur Aktaş
İlknur Aktaş
The most common entrapment neuropathy is carpal tunnel syndrome (CTS), which is caused by compression of the median nerve as it travels through the carpal tunnel in the wrist. Nerve conduction studies (NCS) and ultrasound were used to diagnose CTS but neither method is 100% accurate. The benefit of perineural dextrose injection has been supported in the literature. This article presents three cases with bifid median nerve (BMN) in whom median nerve entrapments were not detected with NCS, and symptom relief was provided with hydrodissection with 2 ml 5% dextrose.

21 March 2023 in The Foot
Verified
Journal Article
Closed access
GGGamze Gül Güleç
Gamze Gül Güleç
MYMustafa T. Yıldızgören
Mustafa T. Yıldızgören
FBFatih Bağcier
Fatih Bağcier

24 July 2025 in Turkish Journal of Osteoporosis
Verified
Journal Article
Open access
PDF file
GGGamze Gül Güleç
Gamze Gül Güleç
ÖBÖzge Özpolat Bulut
Özge Özpolat Bulut
FBFatih Bağıcer
Fatih Bağıcer
A New Era in Digital Health: Evaluation of Artificial Intelligence Supported Chatbots (ChatGPT-4, BingAI, and Gemini) Responses on Osteoporosis - Turkish Journal of Osteoporosis

9 September 2022 in Indian Journal of Orthopaedics
Verified
Journal Article
Closed access
PDF file
GGGamze Gül Güleç
Gamze Gül Güleç
İAİlknur Aktaş
İlknur Aktaş
FÖFeyza Ü. Özkan
Feyza Ü. Özkan

25 February 2026 in Journal of Back and Musculoskeletal Rehabilitation
Verified
Journal Article
Closed access
GGGamze Gül Güleç
Gamze Gül Güleç
EÖEmre Özmen
Emre Özmen
SKSerdar KOKAR
Serdar KOKAR
Background: Ultrasound-guided perineural injection of 5% dextrose in water (D5W) is considered a safe treatment option associated with clinical improvement in patients with mild-to-moderate carpal tunnel syndrome (CTS). Objective: This study aimed to evaluate the efficacy of ultrasound-guided D5 W injection in patients with varying severities of CTS, including mild, moderate and severe cases. Methods: 36 patients with electrophysiologically confirmed CTS (mild, n = 11; moderate, n = 13; severe, n = 12) received a single ultrasound-guided perineural injection of 5 mL D5W. Patients with severe CTS were included only if surgical treatment was declined or not feasible. Pain, neuropathic pain, symptoms and functional outcomes were assessed using the Visual Analogue Scale (VAS), Douleur Neuropathique en 4 Questions (DN4), and Boston Carpal Tunnel Questionnaire (BCTQ: Symptom Severity Scale [SSS], Functional Status Scale [FSS]) at baseline and weeks 1, 4, 12, and 24. Results: All three groups demonstrated significant within-group improvements in VAS, DN4, SSS, and FSS scores from baseline, with improvements evident by week 1 and maintained throughout the 24-week follow-up period (p < 0.001). Between-group comparisons showed better outcomes in mild and moderate CTS, whereas the severe group achieved significant improvements but with higher outcome scores (p < 0.05). No major adverse events, including hematoma, nerve injury or tendon rupture were observed during follow-up; however, mild and transient injection-site pain was reported in most patients. Conclusion: This study suggests that ultrasound-guided perineural D5W injection is associated with clinically meaningful improvements in pain, symptoms and function in patients with CTS across different severity levels, with less favorable outcomes in severe cases. This treatment may be considered a nonsurgical option for selected patients in whom surgical management is declined or not feasible.